
Elevance Health (ELV) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
49.8B
Net Income
1.7B
3.50%
EPS (Diluted)
$7.72
Balance Sheet Metrics
Total Assets
119.7B
Total Liabilities
77.1B
Shareholders Equity
42.6B
Debt to Equity
1.81
Cash Flow Metrics
Operating Cash Flow
-294.0M
Free Cash Flow
821.0M
Revenue & Profitability Trend
Elevance Health Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 176.8B | 171.3B | 156.6B | 138.6B | 121.9B |
Cost of Goods Sold | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
Gross Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | - | - | 17.7B | 15.9B | 17.4B |
Other Operating Expenses | 39.8B | 37.4B | 30.7B | 26.8B | 9.0B |
Total Operating Expenses | 39.8B | 37.4B | 48.4B | 42.7B | 26.4B |
Operating Income | - | - | - | - | - |
Operating Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Non-Operating Items | |||||
Interest Income | - | - | - | - | - |
Interest Expense | 1.2B | 1.0B | 851.0M | 798.0M | 784.0M |
Other Non-Operating Income | 22.6B | 19.5B | 15.0B | 12.7B | 10.4B |
Pre-tax Income | 7.9B | 7.7B | 7.6B | 8.0B | 6.2B |
Income Tax | 1.9B | 1.7B | 1.7B | 1.8B | 1.7B |
Effective Tax Rate % | 24.5% | 22.3% | 22.5% | 23.1% | 26.7% |
Net Income | 6.0B | 6.0B | 5.9B | 6.1B | 4.6B |
Net Margin % | 3.4% | 3.5% | 3.8% | 4.4% | 3.8% |
Key Metrics | |||||
EBITDA | - | - | - | - | - |
EPS (Basic) | $25.81 | $25.69 | $25.32 | $25.25 | $18.63 |
EPS (Diluted) | $25.68 | $25.22 | $24.81 | $24.73 | $17.98 |
Basic Shares Outstanding | 231700000 | 233071088 | 237958067 | 241770746 | 245401430 |
Diluted Shares Outstanding | 231700000 | 233071088 | 237958067 | 241770746 | 245401430 |
Income Statement Trend
Elevance Health Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 8.3B | 6.5B | 7.4B | 4.9B | 5.7B |
Short-term Investments | 25.2B | 29.6B | 26.0B | 26.3B | 23.4B |
Accounts Receivable | 8.0B | 7.9B | 7.1B | 5.7B | 5.3B |
Inventory | - | - | - | - | - |
Other Current Assets | - | - | - | - | - |
Total Current Assets | - | - | - | - | - |
Non-Current Assets | |||||
Property, Plant & Equipment | - | - | - | - | - |
Goodwill | 68.6B | 60.9B | 59.1B | 59.1B | 52.8B |
Intangible Assets | 12.1B | 10.3B | 10.3B | 10.6B | 9.4B |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | - | - | - | - | - |
Total Non-Current Assets | - | - | - | - | - |
Total Assets | 116.9B | - | - | - | - |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 22.7B | 23.0B | 21.2B | 18.5B | 16.9B |
Short-term Debt | 2.0B | 1.9B | 1.8B | 1.9B | 700.0M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | - | - | - | - | - |
Total Current Liabilities | - | - | - | - | - |
Non-Current Liabilities | |||||
Long-term Debt | 29.2B | 23.2B | 22.3B | 21.2B | 19.3B |
Deferred Tax Liabilities | 2.1B | 2.0B | 2.0B | 2.8B | 2.0B |
Other Non-Current Liabilities | - | - | - | - | - |
Total Non-Current Liabilities | - | - | - | - | - |
Total Liabilities | 75.5B | - | - | - | - |
Equity | |||||
Common Stock | 2.0M | 2.0M | 2.0M | 2.0M | 3.0M |
Retained Earnings | 33.5B | 31.7B | 29.6B | 27.1B | 23.8B |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 41.4B | 39.4B | 36.3B | 36.1B | 33.2B |
Key Metrics | |||||
Total Debt | 31.2B | 25.1B | 24.1B | 23.0B | 20.0B |
Working Capital | 0 | 0 | 0 | 0 | 0 |
Balance Sheet Composition
Elevance Health Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 6.0B | 6.0B | 5.9B | 6.1B | 4.6B |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | 191.0M | 289.0M | 264.0M | 255.0M | 283.0M |
Working Capital Changes | 121.0M | -682.0M | -2.0B | -1.4B | 1.7B |
Operating Cash Flow | 5.9B | 5.0B | 4.0B | 5.3B | 6.0B |
Investing Activities | |||||
Capital Expenditures | -1.3B | -1.3B | -1.2B | -1.1B | -1.0B |
Acquisitions | -4.4B | -1.6B | -649.0M | -3.5B | -2.0B |
Investment Purchases | -18.0B | -16.2B | -24.9B | -18.7B | -19.5B |
Investment Sales | 18.6B | 13.5B | 22.6B | 14.6B | 16.1B |
Investing Cash Flow | -5.2B | -5.6B | -4.6B | -9.6B | -7.3B |
Financing Activities | |||||
Share Repurchases | -2.9B | -2.7B | -2.3B | -1.9B | -2.7B |
Dividends Paid | -1.5B | -1.4B | -1.2B | -1.1B | -954.0M |
Debt Issuance | 7.7B | 2.6B | 3.1B | 3.5B | 2.5B |
Debt Repayment | -2.4B | -2.2B | -3.6B | -2.5B | -3.8B |
Financing Cash Flow | 274.0M | -3.7B | -3.5B | -2.2B | -5.3B |
Free Cash Flow | 4.6B | 6.8B | 7.2B | 7.3B | 9.7B |
Net Change in Cash | 1.0B | -4.3B | -4.0B | -6.5B | -6.5B |
Cash Flow Trend
Elevance Health Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
13.14
Forward P/E
8.86
Price to Book
1.59
Price to Sales
0.37
PEG Ratio
-0.60
Profitability Ratios
Profit Margin
2.83%
Operating Margin
5.29%
Return on Equity
12.42%
Return on Assets
4.65%
Financial Health
Current Ratio
1.44
Debt to Equity
68.84
Beta
0.59
Per Share Data
EPS (TTM)
$23.56
Book Value per Share
$194.46
Revenue per Share
$828.61
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
elv | 69.7B | 13.14 | 1.59 | 12.42% | 2.83% | 68.84 |
UnitedHealth | 244.5B | 11.69 | 2.58 | 21.65% | 5.04% | 75.58 |
CVS Health | 87.0B | 19.11 | 1.12 | 5.88% | 1.18% | 106.67 |
Cigna | 79.2B | 16.28 | 1.97 | 13.18% | 1.92% | 76.10 |
Humana | 33.9B | 21.59 | 1.86 | 9.03% | 1.28% | 70.63 |
Centene | 14.0B | 6.92 | 0.51 | 7.44% | 1.29% | 63.91 |
Financial data is updated regularly. All figures are in the company's reporting currency.